Efficacy of polyclonal antibodies for treatment of ocular herpes simplex infection

Cornea

Volumn 20, Issue 5, 2001, Pages 495-500

  Epstein, Seth P ^a   Nurozler, Methiye ^a   Smetana, Caroline R ^a   Asbell, Penny A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antibody; Antiviral treatment; Herpes simplex virus; Herpetic keratitis; Immunoglobulin; Ocular herpes; Pharmaceuticals; Polyclonal antibodies

Indexed keywords

GLYCOPROTEIN D; POLYCLONAL ANTIBODY; POLYCLONAL ANTIBODY SP 510; POLYCLONAL ANTIBODY SP 511; TRIFLURIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; ASSAY; BIOMICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EYE INFECTION; FEMALE; HERPES SIMPLEX KERATITIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; VERO CELL; VIRUS CULTURE; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; CHICKENS; CONJUNCTIVA; CORNEA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HERPESVIRUS 1, HUMAN; IMMUNOTHERAPY; KERATITIS, HERPETIC; RABBITS; TRIFLURIDINE; VERO CELLS; VIRAL ENVELOPE PROTEINS;

EID: 0034968433     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200107000-00011     Document Type: Article

References (41)

1. Herpes simplex eye infections: Clinical manifestations, pathogenesis and management
2. Herpes simplex in a developing country: Natural history and treatment of epithelial ulcers in Tunisia
3. Ocular antivirals
4. The response of Langerhans cells in the cornea to herpetic keratitis
5. 40 virus in tissue culture
6. Nutrition of animal cells in tissue culture. I. Initial studies on a synthetic medium
7. Strain specificity of clinical isolates of herpes simplex virus
8. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice
9. Quantification of herpes simplex virus in rabbit corneal epithelium
10. Systemic antiviral drugs used in ophthalmology: A therapeutic review
11. Phototherapeutic keratectomy in herpes simplex keratitis
12. Excimer laser phototherapeutic keratectomy
13. Preparation and efficacy of antiherpes type 1 and 2 subunit vaccines
14. Rapid diagnosis procedure for virus neutralization test
15. Photorefractive keratectomy: The Sankara Nethralaya experience
16. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease
17. Host defenses in herpes simplex infections of the nervous system: Effect antibody on disease and viral spread
18. Acute and latent infection of sensory ganglia with herpes simplex virus: Immune control and virus reactivation
19. Latency of herpes simplex virus in absence of neutralizing antibody: Model for reactivation
20. Role of antibody in primary and recurrent herpes simplex virus infection
21. Maintenance of latent herpetic infection: An apparent role for anti-viral IgG
22. Specificity of the immune response of mice to herpes simplex virus glycoprotein B and D constitutively expressed on L cell lines
23. Immunogenicity of herpes simplex virus type 2 glycoproteins expressed in vaccinia virus recombinants
24. Herpes simplex virus type 1 - Vaccinia recombinant expressing glycoprotein B: Protection from acute and latent infection
25. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies
26. Analysis of the role of antibody-dependent cellular cytoxicity antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B
27. Role of antibody-dependent cellular cytotoxicity in defense against herpes simplex virus infection
28. Human neonatal and maternal monocyte-macrophage and lymphocyte-mediated antibody-dependent cytotoxicity to cells infected with herpes simplex
29. Herpes virus infections in pregnancy: A comparison of neutralizing antibody titers in mothers and their infants
30. Antibody-dependent cell mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus
31. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes
32. Prevention of varicella by zoster immunoglobulin
33. Zoster immune globulin. A further assessment
34. Prophylaxis of varicella in children with neoplastic disease: Comparative results with zoster immune plasma and gamma globulin
35. Prophylaxis of varicella in high risk children: Dose-response effect of zoster immune globulin
36. Prevention of transfusion-acquired cytomegalovirus infection in newborn infants
37. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation
38. Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease